Skill 5-8 | Administering an Intramuscular Injection | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intramuscular injections deliver medication through the skin and subcutaneous tissues into certain muscles. Muscles have a larger and a greater number of blood vessels than subcutaneous tissue, allowing faster onset of action than with subcutaneous injections. An intramuscular injection is chosen when a reasonably rapid systemic uptake of the drug is needed by the body and when a relatively prolonged action is required. Some medications administered intramuscularly are formulated to have a longer duration of effect. The deposit of medication creates a depot at the injection site, designed to deliver slow, sustained release over hours, days, or weeks. It is important to choose the right needle length for a particular intramuscular injection. Needle length should be based on the individual patient. (See Table 5-1 for intramuscular needle length recommendations.) Patients who are obese may require a longer needle (Wolicki & Miller, 2020), and emaciated patients may require a shorter needle. Appropriate gauge is determined by the medication being administered. In general, biologic agents and medications in aqueous solutions should be administered with a 20- to 25-gauge needle. Medications in oil-based solutions should be administered with an 18- to 25-gauge needle. Many medications come in prefilled syringe units. If a needle is provided on the prefilled unit, ensure that the needle on the unit is the appropriate length for the patient and situation. To avoid complications, the nurse must be able to identify anatomic landmarks and site boundaries. See Figure 1 for a depiction of anatomic landmarks and site boundaries for potential intramuscular injection sites. Consider the age of the patient, medication type, and medication volume when selecting an intramuscular injection site. (See Table 5-2 for information related to intramuscular site selection.) Rotate the sites used to administer intramuscular medications when therapy requires repeated injections. Depending on the site selected, it may be necessary to reposition the patient (refer to Table 5-3). Administer the intramuscular injection so that the needle is perpendicular to the patient's body. This ensures it is given using a 90-degree angle of injection (CDC, 2021). Figure 5-1 in the chapter opener on page 200 shows the angle of insertion for intramuscular injections. The medication volume that can be administered intramuscularly varies based on the intended site. In general, 1 to 5 mL is the accepted volume range, with a limitation of 1 mL of solution at the deltoid site. However, up to 2 mL may be administered at the deltoid site, depending on the size of the individual patient's muscle (Gutierrez & Munakomi, 2021). The less-developed muscles of children and older people limit the intramuscular injection to 1 to 2 mL. Many of the drugs given intramuscularly can cause irritation to subcutaneous tissues when backflow into the tissues occurs along the injection track. Therefore, the Z-track technique is recommended for all intramuscular injections (particularly nonvaccine injections) to ensure that medication does not leak back along the needle track and into the subcutaneous tissue (Hopkins & Arias, 2013; Karch, 2020; Yilmaz et al., 2016). This technique reduces pain and discomfort (Şanlialp Zeyrek et al., 2019), particularly for patients receiving injections over an extended period. The Z-track method is also suggested for older adults who have decreased muscle mass. Some medications, such as iron, are best given via the Z-track method due to the irritation and discoloration associated with the medication (Karch, 2020). An alternative method for intramuscular injection is to stretch the skin flat between two fingers and hold it taut for needle insertion. The decision regarding use of the Z-track method or stretching the skin at the site is based on the individual patient and nursing judgment (Taylor et al., 2023). Knowledge of landmarks and risks, along with an assessment of muscle size and consideration of the medication itself are of paramount importance for the nurse. Aspiration, or pulling back on the plunger to check if a blood vessel has been entered, is not necessary and has not proved to be a reliable indicator of needle placement. The use of correct technique and recommended anatomic injection sites results in a very small likelihood of injecting into a blood vessel and there is no scientific evidence to support aspiration (CDC, 2021; Davidson & Rourke, 2013; Sisson, 2015). The World Health Organization (WHO, 2020) and CDC (2015a) do not include aspiration in the steps for intramuscular injection of vaccines. The wide-spread use of auto-disable (AD) syringes encouraged by the WHO (2020) further reinforces no aspiration with intramuscular vaccine administration, since most AD syringes are not designed to aspirate (Sepah et al., 2017). Some medication manufacturers indicate that aspiration may be recommended when administering certain medications, at certain dosages and certain rates, but more research needs to be done on this topic (Mraz et al., 2018; Sepah et al., 2017; Thomas et al., 2016). Consult facility policy and manufacturer recommendations to ensure safe administration. Refer to Box 5-1 in Skill 5-7 on page 237 for techniques for reducing discomfort when injecting medications subcutaneously or intramuscularly. The following skill outlines administration of an intramuscular injection using the Z-track technique. If, based on assessment of the particular circumstances for an individual patient, the nurse decides not to use the Z-track technique, the skin should be stretched flat between two fingers and held taut for needle insertion. Delegation Considerations The administration of an intramuscular injection is not delegated to assistive personnel (AP). Depending on the state's nurse practice act and the organization's policies and procedures, the administration of an intramuscular injection may be delegated to licensed practical/vocational nurses (LPN/LVNs). The decision to delegate must be based on careful analysis of the patient's needs and circumstances as well as the qualifications of the person to whom the task is being delegated. Refer to the Delegation Guidelines in Appendix A. Assessment Assess the appropriateness of the drug for the patient. Review the medical history and allergy, assessment, and laboratory data that may influence drug administration. Check the expiration date. Assess the site on the patient where the injection is to be given. Avoid any site that is bruised, tender, hard, swollen, inflamed, or scarred. Assess the patient's knowledge of the medication. If the patient has deficient knowledge about the medication, this may be the appropriate time to begin education about it. If the medication may affect the patient's vital signs, assess them before administration. If the medication is intended for pain relief, assess the patient's pain before and after administration. Verify patient name, dose, route, and time of administration. Actual or Potential Health Problems and Needs Many actual or potential health problems or issues may require the use of this skill as part of related interventions. An appropriate health problem or issue may include: Outcome Identification and Planning The expected outcomes to achieve when administering an intramuscular injection are that the patient receives the medication via the intramuscular route and experiences the intended effect of the medication, the patient does not experience adverse effects, and the patient verbalizes an understanding of the medication regimen. Implementation
Documentation Guidelines Record each medication given on the eMAR/MAR or record using the required format, including date, time, and the site of administration, immediately after administration. If using a bar-code system, medication administration is automatically recorded when the bar code is scanned. PRN medications require documentation of the reason for administration. Prompt recording avoids the possibility of accidentally repeating the administration of the drug. If the drug was refused or omitted, record this in the appropriate area on the medication record and notify the health care team as appropriate. This verifies the reason medication was omitted and ensures that health care personnel providing care for the patient are aware of the occurrence. Developing Clinical Reasoning and Clinical Judgment Unexpected Situations and Associated Interventions
Special Considerations General Considerations
Infant and Child Considerations
Community-Based Care Considerations
|